Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).
Dutch otolaryngologist Marein van der Torn hoped to develop a prosthesis that would improve the voice of people who had lost their vocal cords. He investigated the possibilities of a new type of voice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback